Attached files
file | filename |
---|---|
EX-10.1 - EX-10.1 - Oak Street Health, Inc. | d99031dex101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 2020
Oak Street Health, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-39427 | 84-3446686 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
30 W. Monroe Street
Suite 1200
Chicago, Illinois 60603
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (312) 733-9730
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, $0.001 par value | OSH | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 | Entry into a Material Definitive Agreement |
On October 2, 2020, Oak Street Health, Inc. (the Company) awarded independent director Kim Keck 70,000 restricted stock units in connection with Ms. Kecks services on the Companys Board of Directors, contingent upon obtaining shareholder approval of the award at the Companys next annual meeting of shareholders. The restricted stock units are subject to vesting as described in the Restricted Stock Unit Award Agreement attached hereto as Exhibit 10.1. If approved by the Companys shareholders, upon vesting, the restricted stock units will be settled by issuing 70,000 shares of the Companys common stock, par value $0.001 per share to Ms. Keck.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit |
Description | |
10.1 | Restricted Stock Unit Award Agreement with Kim Keck dated October 1, 2020. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 2, 2020
Oak Street Health, Inc. | ||
By: | /s/ Michael Pykosz | |
Name: Title: |
Michael Pykosz Chief Executive Officer |
3